(Q56567724)

English

Adiposopathy: why do adiposity and obesity cause metabolic disease?

article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

0 references

Adiposopathy: why do adiposity and obesity cause metabolic disease? (English)

0 references

0 references

author name string

Harold Bays

1

0 references

Christie Ballantyne

2

0 references

publication date

August 2006

0 references

Clinical Lipidology

0 references

1

0 references

4

0 references

389-420

0 references

Adiposopathy, metabolic syndrome, quantum physics, general relativity, chaos and the Theory of Everything

1 reference

https://api.crossref.org/works/10.2217%2F17460875.1.4.389

21 January 2018

Adiposopathy: sick fat causes high blood sugar, high blood pressure and dyslipidemia

1 reference

https://api.crossref.org/works/10.2217%2F17460875.1.4.389

21 January 2018

Adiposopathy is a more rational treatment target for metabolic disease than obesity alone

1 reference

https://api.crossref.org/works/10.2217%2F17460875.1.4.389

21 January 2018

Metabolic and body composition factors in subgroups of obesity: what do we know?

1 reference

https://api.crossref.org/works/10.2217%2F17460875.1.4.389

21 January 2018

Current and investigational antiobesity agents and obesity therapeutic treatment targets

1 reference

https://api.crossref.org/works/10.2217%2F17460875.1.4.389

21 January 2018

Role of the adipocyte, free fatty acids, and ectopic fat in pathogenesis of type 2 diabetes mellitus: peroxisomal proliferator-activated receptor agonists provide a rational therapeutic approach

1 reference

https://api.crossref.org/works/10.2217%2F17460875.1.4.389

21 January 2018

Diabetes, lipids, and adipocyte secretagogues

1 reference

https://api.crossref.org/works/10.2217%2F17460875.1.4.389

21 January 2018

Adipose tissue as an endocrine organ

1 reference

https://api.crossref.org/works/10.2217%2F17460875.1.4.389

21 January 2018

The inflammatory syndrome: the role of adipose tissue cytokines in metabolic disorders linked to obesity

1 reference

https://api.crossref.org/works/10.2217%2F17460875.1.4.389

21 January 2018

Lysophosphatidic acid inhibits adipocyte differentiation via lysophosphatidic acid 1 receptor-dependent down-regulation of peroxisome proliferator-activated receptor gamma2.

1 reference

https://api.crossref.org/works/10.2217%2F17460875.1.4.389

21 January 2018

VLDL induces adipocyte differentiation in ApoE-dependent manner

1 reference

https://api.crossref.org/works/10.2217%2F17460875.1.4.389

21 January 2018

Arachidonic acid and prostacyclin signaling promote adipose tissue development: a human health concern?

1 reference

https://api.crossref.org/works/10.2217%2F17460875.1.4.389

21 January 2018

Leptin-induced adipose apoptosis: Implications for body weight regulation.

1 reference

https://api.crossref.org/works/10.2217%2F17460875.1.4.389

21 January 2018

The biology of white adipocyte proliferation

1 reference

https://api.crossref.org/works/10.2217%2F17460875.1.4.389

21 January 2018

Epidermal growth factor promotes adipogenesis of 3T3-L1 cell in vitro

1 reference

https://api.crossref.org/works/10.2217%2F17460875.1.4.389

21 January 2018

11beta-hydroxysteroid dehydrogenase type 1: a tissue-specific regulator of glucocorticoid response

1 reference

https://api.crossref.org/works/10.2217%2F17460875.1.4.389

21 January 2018

Novel treatments for obesity and osteoporosis: targeting apoptotic pathways in adipocytes

1 reference

https://api.crossref.org/works/10.2217%2F17460875.1.4.389

21 January 2018

Surgical implantation of adipose tissue reverses diabetes in lipoatrophic mice

1 reference

https://api.crossref.org/works/10.2217%2F17460875.1.4.389

21 January 2018

The expression of adipogenic genes is decreased in obesity and diabetes mellitus

1 reference

https://api.crossref.org/works/10.2217%2F17460875.1.4.389

21 January 2018

Failure of fat cell proliferation, mitochondrial function and fat oxidation results in ectopic fat storage, insulin resistance and type II diabetes mellitus

1 reference

https://api.crossref.org/works/10.2217%2F17460875.1.4.389

21 January 2018

Mechanism of insulin-resistant glucose transport activity in the enlarged adipose cell of the aged, obese rat.

1 reference

https://api.crossref.org/works/10.2217%2F17460875.1.4.389

21 January 2018

Cholesterol, a cell size-dependent signal that regulates glucose metabolism and gene expression in adipocytes

1 reference

https://api.crossref.org/works/10.2217%2F17460875.1.4.389

21 January 2018

From big fat cells to high blood pressure: a pathway to obesity-associated hypertension

1 reference

https://api.crossref.org/works/10.2217%2F17460875.1.4.389

21 January 2018

Obesity is associated with macrophage accumulation in adipose tissue

1 reference

https://api.crossref.org/works/10.2217%2F17460875.1.4.389

21 January 2018

Adipokines: inflammation and the pleiotropic role of white adipose tissue

1 reference

https://api.crossref.org/works/10.2217%2F17460875.1.4.389

21 January 2018

Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance

1 reference

https://api.crossref.org/works/10.2217%2F17460875.1.4.389

21 January 2018

Pathophysiology of coronary artery disease

1 reference

https://api.crossref.org/works/10.2217%2F17460875.1.4.389

21 January 2018

Inflammation and atherosclerosis

1 reference

https://api.crossref.org/works/10.2217%2F17460875.1.4.389

21 January 2018

Adipose tissue, inflammation, and cardiovascular disease

1 reference

https://api.crossref.org/works/10.2217%2F17460875.1.4.389

21 January 2018

Adipokines: molecular links between obesity and atheroslcerosis

1 reference

https://api.crossref.org/works/10.2217%2F17460875.1.4.389

21 January 2018

Obesity, Metabolic Syndrome, and Cardiovascular Disease

1 reference

https://api.crossref.org/works/10.2217%2F17460875.1.4.389

21 January 2018

Development of the multiple metabolic syndrome in the ARIC cohort: joint contribution of insulin, BMI, and WHR. Atherosclerosis risk in communities

1 reference

https://api.crossref.org/works/10.2217%2F17460875.1.4.389

21 January 2018

Pharmacotherapy to reduce visceral fat.

1 reference

https://api.crossref.org/works/10.2217%2F17460875.1.4.389

21 January 2018

Abdominal obesity and dyslipidemia in the metabolic syndrome: importance of type 2 diabetes and familial combined hyperlipidemia in coronary artery disease risk

1 reference

https://api.crossref.org/works/10.2217%2F17460875.1.4.389

21 January 2018

Therapy Insight: adipocytokines in metabolic syndrome and related cardiovascular disease

1 reference

https://api.crossref.org/works/10.2217%2F17460875.1.4.389

21 January 2018

Interrelationship between serum lipid profile, serum hormones and other components of the metabolic syndrome.

1 reference

https://api.crossref.org/works/10.2217%2F17460875.1.4.389

21 January 2018

Modulation of adipocyte lipoprotein lipase expression as a strategy for preventing or treating visceral obesity

1 reference

https://api.crossref.org/works/10.2217%2F17460875.1.4.389

21 January 2018

Medical Consequences of Obesity

1 reference

https://api.crossref.org/works/10.2217%2F17460875.1.4.389

21 January 2018

Adipocytokines: emerging therapeutic targets

1 reference

https://api.crossref.org/works/10.2217%2F17460875.1.4.389

21 January 2018

Effects of weight loss and pharmacotherapy on inflammatory markers of cardiovascular disease

1 reference

https://api.crossref.org/works/10.2217%2F17460875.1.4.389

21 January 2018

Inflammation, insulin resistance, and obesity.

1 reference

https://api.crossref.org/works/10.2217%2F17460875.1.4.389

21 January 2018

Adipose tissue, adipokines, and inflammation

1 reference

https://api.crossref.org/works/10.2217%2F17460875.1.4.389

21 January 2018

Eotaxin and obesity

1 reference

https://api.crossref.org/works/10.2217%2F17460875.1.4.389

21 January 2018

A paradox resolved: the postprandial model of insulin resistance explains why gynoid adiposity appears to be protective

1 reference

https://api.crossref.org/works/10.2217%2F17460875.1.4.389

21 January 2018

Enlarged subcutaneous abdominal adipocyte size, but not obesity itself, predicts type II diabetes independent of insulin resistance

1 reference

https://api.crossref.org/works/10.2217%2F17460875.1.4.389

21 January 2018

Adipocyte signaling and lipid homeostasis: sequelae of insulin-resistant adipose tissue

1 reference

https://api.crossref.org/works/10.2217%2F17460875.1.4.389

21 January 2018

Redefining type 2 diabetes: 'diabesity' or 'obesity dependent diabetes mellitus'?

1 reference

https://api.crossref.org/works/10.2217%2F17460875.1.4.389

21 January 2018

Obesity and type 2 diabetes

1 reference

https://api.crossref.org/works/10.2217%2F17460875.1.4.389

21 January 2018

Hypertension and obesity

1 reference

https://api.crossref.org/works/10.2217%2F17460875.1.4.389

21 January 2018

Obesity-hypertension: the effects on cardiovascular and renal systems

1 reference

https://api.crossref.org/works/10.2217%2F17460875.1.4.389

21 January 2018

Human adipocytes secrete mineralocorticoid-releasing factors

1 reference

https://api.crossref.org/works/10.2217%2F17460875.1.4.389

21 January 2018

Overexpression of 11beta-hydroxysteroid dehydrogenase-1 in adipose tissue is associated with acquired obesity and features of insulin resistance: studies in young adult monozygotic twins

1 reference

https://api.crossref.org/works/10.2217%2F17460875.1.4.389

21 January 2018

Weight loss increases 11beta-hydroxysteroid dehydrogenase type 1 expression in human adipose tissue

1 reference

https://api.crossref.org/works/10.2217%2F17460875.1.4.389

21 January 2018

11beta-hydroxysteroid dehydrogenase type 1 activity in lean and obese males with type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.2217%2F17460875.1.4.389

21 January 2018

Local and systemic impact of transcriptional up-regulation of 11beta-hydroxysteroid dehydrogenase type 1 in adipose tissue in human obesity

1 reference

https://api.crossref.org/works/10.2217%2F17460875.1.4.389

21 January 2018

Tissue-specific dysregulation of 11beta-hydroxysteroid dehydrogenase type 1 and pathogenesis of the metabolic syndrome

1 reference

https://api.crossref.org/works/10.2217%2F17460875.1.4.389

21 January 2018

Novel adipose tissue-mediated resistance to diet-induced visceral obesity in 11 beta-hydroxysteroid dehydrogenase type 1-deficient mice

1 reference

https://api.crossref.org/works/10.2217%2F17460875.1.4.389

21 January 2018

The Effects of Adrenal Corticosteroids on Regional Adipocyte Size in Man

1 reference

https://api.crossref.org/works/10.2217%2F17460875.1.4.389

21 January 2018

Morbidity and mortality in Cushing's disease: an epidemiological approach

1 reference

https://api.crossref.org/works/10.2217%2F17460875.1.4.389

21 January 2018

Computed tomography assessment of fat distribution in male and female patients with Cushing's syndrome.

1 reference

https://api.crossref.org/works/10.2217%2F17460875.1.4.389

21 January 2018

Molecular regulation of adipogenesis

1 reference

https://api.crossref.org/works/10.2217%2F17460875.1.4.389

21 January 2018

Tissue-specific glucocorticoid reactivating enzyme, 11 beta-hydroxysteroid dehydrogenase type 1 (11 beta-HSD1)--a promising drug target for the treatment of metabolic syndrome

1 reference

https://api.crossref.org/works/10.2217%2F17460875.1.4.389

21 January 2018

Does central obesity reflect "Cushing's disease of the omentum"?

1 reference

https://api.crossref.org/works/10.2217%2F17460875.1.4.389

21 January 2018

Plasma acylation stimulating protein, adipsin and lipids in non-obese and obese populations

1 reference

https://api.crossref.org/works/10.2217%2F17460875.1.4.389

21 January 2018

The adipocyte as an endocrine cell

1 reference

https://api.crossref.org/works/10.2217%2F17460875.1.4.389

21 January 2018

Adipose tissues as an ancestral immune organ: site-specific change in obesity.

1 reference

https://api.crossref.org/works/10.2217%2F17460875.1.4.389

21 January 2018

Critical review of acylation-stimulating protein physiology in humans and rodents

1 reference

https://api.crossref.org/works/10.2217%2F17460875.1.4.389

21 January 2018

Novel roles for acylation stimulating protein/C3adesArg: a review of recent in vitro and in vivo evidence

1 reference

https://api.crossref.org/works/10.2217%2F17460875.1.4.389

21 January 2018

The association between plasma adiponectin and insulin sensitivity in humans depends on obesity

1 reference

https://api.crossref.org/works/10.2217%2F17460875.1.4.389

21 January 2018

Adipocytokines: leptin--the classical, resistin--the controversical, adiponectin--the promising, and more to come

1 reference

https://api.crossref.org/works/10.2217%2F17460875.1.4.389

21 January 2018

Update on adipocyte hormones: regulation of energy balance and carbohydrate/lipid metabolism

1 reference

https://api.crossref.org/works/10.2217%2F17460875.1.4.389

21 January 2018

The insulin-sensitizing role of the fat derived hormone adiponectin

1 reference

https://api.crossref.org/works/10.2217%2F17460875.1.4.389

21 January 2018

Relationship between serum adiponectin and leptin concentrations and body fat distribution

1 reference

https://api.crossref.org/works/10.2217%2F17460875.1.4.389

21 January 2018

Leptin and adiponectin in relation to body fat percentage, waist to hip ratio and the apoB/apoA1 ratio in Asian Indian and Caucasian men and women

1 reference

https://api.crossref.org/works/10.2217%2F17460875.1.4.389

21 January 2018

Impact of the renin-angiotensin system on lipid and carbohydrate metabolism.

1 reference

https://api.crossref.org/works/10.2217%2F17460875.1.4.389

21 January 2018

Evidence for a local angiotensin-generating system and dose-dependent inhibition of glucose-stimulated insulin release by angiotensin II in isolated pancreatic islets

1 reference

https://api.crossref.org/works/10.2217%2F17460875.1.4.389

21 January 2018

Autotaxin has lysophospholipase D activity leading to tumor cell growth and motility by lysophosphatidic acid production

1 reference

https://api.crossref.org/works/10.2217%2F17460875.1.4.389

21 January 2018

Potential involvement of adipocyte insulin resistance in obesity-associated up-regulation of adipocyte lysophospholipase D/autotaxin expression

1 reference

https://api.crossref.org/works/10.2217%2F17460875.1.4.389

21 January 2018

Autotaxin is released from adipocytes, catalyzes lysophosphatidic acid synthesis, and activates preadipocyte proliferation. Up-regulated expression with adipocyte differentiation and obesity

1 reference

https://api.crossref.org/works/10.2217%2F17460875.1.4.389

21 January 2018

A role for sphingolipids in producing the common features of type 2 diabetes, metabolic syndrome X, and Cushing's syndrome

1 reference

https://api.crossref.org/works/10.2217%2F17460875.1.4.389

21 January 2018

Current status and perspectives in ceramide-targeting molecular medicine

1 reference

https://api.crossref.org/works/10.2217%2F17460875.1.4.389

21 January 2018

Inhibitory effect of ceramide on insulin-induced protein kinase Czeta translocation in rat adipocytes

1 reference

https://api.crossref.org/works/10.2217%2F17460875.1.4.389

21 January 2018

Lipid mediators of insulin resistance: ceramide signalling down-regulates GLUT4 gene transcription in 3T3-L1 adipocytes

1 reference

https://api.crossref.org/works/10.2217%2F17460875.1.4.389

21 January 2018

Acid ceramidase overexpression prevents the inhibitory effects of saturated fatty acids on insulin signaling

1 reference

https://api.crossref.org/works/10.2217%2F17460875.1.4.389

21 January 2018

Fat mobilization in adipose tissue is promoted by adipose triglyceride lipase

1 reference

https://api.crossref.org/works/10.2217%2F17460875.1.4.389

21 January 2018

Hormone-sensitive lipase--new roles for an old enzyme

1 reference

https://api.crossref.org/works/10.2217%2F17460875.1.4.389

21 January 2018

Free insulin-like growth factors in human obesity

1 reference

https://api.crossref.org/works/10.2217%2F17460875.1.4.389

21 January 2018

The role of the growth hormone-insulin-like growth factor axis in glucose homeostasis.

1 reference

https://api.crossref.org/works/10.2217%2F17460875.1.4.389

21 January 2018

Circulating levels of free insulin-like growth factors in obese subjects: the impact of type 2 diabetes

1 reference

https://api.crossref.org/works/10.2217%2F17460875.1.4.389

21 January 2018

Reversing adipocyte differentiation: implications for treatment of obesity

1 reference

https://api.crossref.org/works/10.2217%2F17460875.1.4.389

21 January 2018

Rethinking leptin and insulin action: therapeutic opportunities for diabetes.

1 reference

https://api.crossref.org/works/10.2217%2F17460875.1.4.389

21 January 2018

Leptin levels in obese women with and without type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.2217%2F17460875.1.4.389

21 January 2018

Direct and indirect effects of leptin on preadipocyte proliferation and differentiation

1 reference

https://api.crossref.org/works/10.2217%2F17460875.1.4.389

21 January 2018

Porcine preadipocyte proliferation and differentiation: a role for leptin?

1 reference

https://api.crossref.org/works/10.2217%2F17460875.1.4.389

21 January 2018

Proadipogenic effect of leptin on rat preadipocytes in vitro: activation of MAPK and STAT3 signaling pathways

1 reference

https://api.crossref.org/works/10.2217%2F17460875.1.4.389

21 January 2018

The fat and thin of lipin.

1 reference

https://api.crossref.org/works/10.2217%2F17460875.1.4.389

21 January 2018

Cross-species analyses implicate Lipin 1 involvement in human glucose metabolism

1 reference

https://api.crossref.org/works/10.2217%2F17460875.1.4.389

21 January 2018

Perilipin expression in human adipose tissue is elevated with obesity

1 reference

https://api.crossref.org/works/10.2217%2F17460875.1.4.389

21 January 2018

Perilipin targets a novel pool of lipid droplets for lipolytic attack by hormone-sensitive lipase

1 reference

https://api.crossref.org/works/10.2217%2F17460875.1.4.389

21 January 2018

Perilipin expression in human adipose tissues: effects of severe obesity, gender, and depot

1 reference

https://api.crossref.org/works/10.2217%2F17460875.1.4.389

21 January 2018

Increased fatty acid re-esterification by PEPCK overexpression in adipose tissue leads to obesity without insulin resistance

1 reference

https://api.crossref.org/works/10.2217%2F17460875.1.4.389

21 January 2018

Proposed involvement of adipocyte glyceroneogenesis and phosphoenolpyruvate carboxykinase in the metabolic syndrome

1 reference

https://api.crossref.org/works/10.2217%2F17460875.1.4.389

21 January 2018

Glyceroneogenesis comes of age.

1 reference

https://api.crossref.org/works/10.2217%2F17460875.1.4.389

21 January 2018

Adipose overexpression of phosphoenolpyruvate carboxykinase leads to high susceptibility to diet-induced insulin resistance and obesity

1 reference

https://api.crossref.org/works/10.2217%2F17460875.1.4.389

21 January 2018

Different forms of obesity as a function of diet composition

1 reference

https://api.crossref.org/works/10.2217%2F17460875.1.4.389

21 January 2018

The determinants of plasma plasminogen activator inhibitor-1 levels differ for American and Japanese men aged 40-49.

1 reference

https://api.crossref.org/works/10.2217%2F17460875.1.4.389

21 January 2018

Elevated levels of acute-phase proteins and plasminogen activator inhibitor-1 predict the development of type 2 diabetes: the insulin resistance atherosclerosis study

1 reference

https://api.crossref.org/works/10.2217%2F17460875.1.4.389

21 January 2018

Plasminogen activator inhibitor-1 modulates adipocyte differentiation.

1 reference

https://api.crossref.org/works/10.2217%2F17460875.1.4.389

21 January 2018

Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes

1 reference

https://api.crossref.org/works/10.2217%2F17460875.1.4.389

21 January 2018

TNF-alpha inhibits glucose-induced insulin secretion in a pancreatic beta-cell line (INS-1).

1 reference

https://api.crossref.org/works/10.2217%2F17460875.1.4.389

21 January 2018

Tumor necrosis factor-alpha induces skeletal muscle insulin resistance in healthy human subjects via inhibition of Akt substrate 160 phosphorylation

1 reference

https://api.crossref.org/works/10.2217%2F17460875.1.4.389

21 January 2018

Tumor necrosis factor-alpha suppresses adipocyte-specific genes and activates expression of preadipocyte genes in 3T3-L1 adipocytes: nuclear factor-kappaB activation by TNF-alpha is obligatory

1 reference

https://api.crossref.org/works/10.2217%2F17460875.1.4.389

21 January 2018

Plasma visfatin concentrations and fat depot-specific mRNA expression in humans

1 reference

https://api.crossref.org/works/10.2217%2F17460875.1.4.389

21 January 2018

Vaspin gene expression in human adipose tissue: association with obesity and type 2 diabetes

1 reference

https://api.crossref.org/works/10.2217%2F17460875.1.4.389

21 January 2018

Visceral adipose tissue-derived serine protease inhibitor: a unique insulin-sensitizing adipocytokine in obesity

1 reference

https://api.crossref.org/works/10.2217%2F17460875.1.4.389

21 January 2018

Pathophysiology of obesity hypertension

1 reference

https://api.crossref.org/works/10.2217%2F17460875.1.4.389

21 January 2018

Obesity, Sleep Apnea, and Hypertension

1 reference

https://api.crossref.org/works/10.2217%2F17460875.1.4.389

21 January 2018

The heart in obesity-hypertension

1 reference

https://api.crossref.org/works/10.2217%2F17460875.1.4.389

21 January 2018

11 beta-hydroxysteroid dehydrogenase type 1 in obesity and the metabolic syndrome

1 reference

https://api.crossref.org/works/10.2217%2F17460875.1.4.389

21 January 2018

Plasma adiponectin levels and blood pressures in nondiabetic adolescent females

1 reference

https://api.crossref.org/works/10.2217%2F17460875.1.4.389

21 January 2018

Factors that influence the risk of hypertension in obese individuals

1 reference

https://api.crossref.org/works/10.2217%2F17460875.1.4.389

21 January 2018

Physiology and pathophysiology of the adipose tissue renin-angiotensin system

1 reference

https://api.crossref.org/works/10.2217%2F17460875.1.4.389

21 January 2018

High free fatty acid concentration: an independent risk factor for hypertension in the Paris Prospective Study

1 reference

https://api.crossref.org/works/10.2217%2F17460875.1.4.389

21 January 2018

Free fatty acid levels modulate microvascular function: relevance for obesity-associated insulin resistance, hypertension, and microangiopathy

1 reference

https://api.crossref.org/works/10.2217%2F17460875.1.4.389

21 January 2018

Insulin resistance and the sympathetic nervous system

1 reference

https://api.crossref.org/works/10.2217%2F17460875.1.4.389

21 January 2018

Interleukin-6 impairs endothelium-dependent NO-cGMP-mediated relaxation and enhances contraction in systemic vessels of pregnant rats

1 reference

https://api.crossref.org/works/10.2217%2F17460875.1.4.389

21 January 2018

Fasting acylation-stimulating protein is predictive of postprandial triglyceride clearance

1 reference

https://api.crossref.org/works/10.2217%2F17460875.1.4.389

21 January 2018

Proteomic analysis of proteins associated with lipid droplets of basal and lipolytically stimulated 3T3-L1 adipocytes

1 reference

https://api.crossref.org/works/10.2217%2F17460875.1.4.389

21 January 2018

Adipose differentiation related protein (ADRP) expressed in transfected COS-7 cells selectively stimulates long chain fatty acid uptake

1 reference

https://api.crossref.org/works/10.2217%2F17460875.1.4.389

21 January 2018

Adipophilin enhances lipid accumulation and prevents lipid efflux from THP-1 macrophages: potential role in atherogenesis

1 reference

https://api.crossref.org/works/10.2217%2F17460875.1.4.389

21 January 2018

Low plasma adiponectin levels are associated with increased hepatic lipase activity in vivo

1 reference

https://api.crossref.org/works/10.2217%2F17460875.1.4.389

21 January 2018

Triacylglycerol-rich lipoproteins and the generation of small, dense low-density lipoprotein

1 reference

https://api.crossref.org/works/10.2217%2F17460875.1.4.389

21 January 2018

Torcetrapib/atorvastatin combination therapy

1 reference

https://api.crossref.org/works/10.2217%2F17460875.1.4.389

21 January 2018

Decreased plasma lipoprotein lipase in hypoadiponectinemia: an association independent of systemic inflammation and insulin resistance

1 reference

https://api.crossref.org/works/10.2217%2F17460875.1.4.389

21 January 2018

Comparison of a very low-carbohydrate and low-fat diet on fasting lipids, LDL subclasses, insulin resistance, and postprandial lipemic responses in overweight women.

1 reference

https://api.crossref.org/works/10.2217%2F17460875.1.4.389

21 January 2018

Increased serum cholesteryl ester transfer protein in obese children

1 reference

https://api.crossref.org/works/10.2217%2F17460875.1.4.389

21 January 2018

Cholesteryl ester transfer protein gene expression during differentiation of human preadipocytes to adipocytes in primary culture

1 reference

https://api.crossref.org/works/10.2217%2F17460875.1.4.389

21 January 2018

Specific inhibition of hormone-sensitive lipase improves lipid profile while reducing plasma glucose

1 reference

https://api.crossref.org/works/10.2217%2F17460875.1.4.389

21 January 2018

Leptin-replacement therapy for lipodystrophy.

1 reference

https://api.crossref.org/works/10.2217%2F17460875.1.4.389

21 January 2018

Triglycerides induce leptin resistance at the blood-brain barrier

1 reference

https://api.crossref.org/works/10.2217%2F17460875.1.4.389

21 January 2018

Mechanism of action of fibrates on lipid and lipoprotein metabolism

1 reference

https://api.crossref.org/works/10.2217%2F17460875.1.4.389

21 January 2018

Postprandial triglyceride response in visceral obesity in men.

1 reference

https://api.crossref.org/works/10.2217%2F17460875.1.4.389

21 January 2018

Absence of perilipin results in leanness and reverses obesity in Lepr(db/db) mice

1 reference

https://api.crossref.org/works/10.2217%2F17460875.1.4.389

21 January 2018

The central role of perilipin a in lipid metabolism and adipocyte lipolysis

1 reference

https://api.crossref.org/works/10.2217%2F17460875.1.4.389

21 January 2018

Letting lipids go: hormone-sensitive lipase

1 reference

https://api.crossref.org/works/10.2217%2F17460875.1.4.389

21 January 2018

Influence of obesity and insulin sensitivity on phospholipid transfer protein activity

1 reference

https://api.crossref.org/works/10.2217%2F17460875.1.4.389

21 January 2018

The impact of phospholipid transfer protein (PLTP) on HDL metabolism

1 reference

https://api.crossref.org/works/10.2217%2F17460875.1.4.389

21 January 2018

Obesity and endocrine disease

1 reference

https://api.crossref.org/works/10.2217%2F17460875.1.4.389

21 January 2018

Androgens before and after weight loss in obese children

1 reference

https://api.crossref.org/works/10.2217%2F17460875.1.4.389

21 January 2018

Early endocrine, metabolic, and sonographic characteristics of polycystic ovary syndrome (PCOS): comparison between nonobese and obese adolescents

1 reference

https://api.crossref.org/works/10.2217%2F17460875.1.4.389

21 January 2018

Management of diabetic dyslipidemia

1 reference

https://api.crossref.org/works/10.2217%2F17460875.1.4.389

21 January 2018

Effects of adipocyte-derived cytokines on endothelial functions: implication of vascular disease

1 reference

https://api.crossref.org/works/10.2217%2F17460875.1.4.389

21 January 2018

Association of interleukin-6, C-reactive protein, interleukin-10 and adiponectin plasma concentrations with measures of obesity, insulin sensitivity and glucose metabolism

1 reference

https://api.crossref.org/works/10.2217%2F17460875.1.4.389

21 January 2018

Relationships between human serum resistin, inflammatory markers and insulin resistance

1 reference

https://api.crossref.org/works/10.2217%2F17460875.1.4.389

21 January 2018

Human epicardial adipose tissue is a source of inflammatory mediators

1 reference

https://api.crossref.org/works/10.2217%2F17460875.1.4.389

21 January 2018

Human epicardial adipose tissue expresses a pathogenic profile of adipocytokines in patients with cardiovascular disease

1 reference

https://api.crossref.org/works/10.2217%2F17460875.1.4.389

21 January 2018

Adiposity of the heart, revisited

1 reference

https://api.crossref.org/works/10.2217%2F17460875.1.4.389

21 January 2018

The cannabinoid CB1 receptor antagonist SR141716 increases Acrp30 mRNA expression in adipose tissue of obese fa/fa rats and in cultured adipocyte cells

1 reference

https://api.crossref.org/works/10.2217%2F17460875.1.4.389

21 January 2018

Cannabinoid receptors regulate Ca(2+) signals and insulin secretion in pancreatic beta-cell.

1 reference

https://api.crossref.org/works/10.2217%2F17460875.1.4.389

21 January 2018

The endocannabinoid system and the treatment of obesity

1 reference

https://api.crossref.org/works/10.2217%2F17460875.1.4.389

21 January 2018

cAMP-positive regulation of angiotensinogen gene expression and protein secretion in rat adipose tissue

1 reference

https://api.crossref.org/works/10.2217%2F17460875.1.4.389

21 January 2018

The role of the endocannabinoid system in the control of energy homeostasis.

1 reference

https://api.crossref.org/works/10.2217%2F17460875.1.4.389

21 January 2018

The cannabinoid CB1 receptor antagonist rimonabant (SR141716) inhibits cell proliferation and increases markers of adipocyte maturation in cultured mouse 3T3 F442A preadipocytes

1 reference

https://api.crossref.org/works/10.2217%2F17460875.1.4.389

21 January 2018

The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes

1 reference

https://api.crossref.org/works/10.2217%2F17460875.1.4.389

21 January 2018

Anti-obesity drug development

1 reference

https://api.crossref.org/works/10.2217%2F17460875.1.4.389

21 January 2018

Gene-nutrient interactions during fetal development

1 reference

https://api.crossref.org/works/10.2217%2F17460875.1.4.389

21 January 2018

Testosterone inhibits adipogenic differentiation in 3T3-L1 cells: nuclear translocation of androgen receptor complex with beta-catenin and T-cell factor 4 may bypass canonical Wnt signaling to down-regulate adipogenic transcription factors

1 reference

https://api.crossref.org/works/10.2217%2F17460875.1.4.389

21 January 2018

Nitric oxide promotes differentiation of rat white preadipocytes in culture

1 reference

https://api.crossref.org/works/10.2217%2F17460875.1.4.389

21 January 2018

Adiponectin promotes adipocyte differentiation, insulin sensitivity, and lipid accumulation

1 reference

https://api.crossref.org/works/10.2217%2F17460875.1.4.389

21 January 2018

Agouti expression in human adipose tissue: functional consequences and increased expression in type 2 diabetes

1 reference

https://api.crossref.org/works/10.2217%2F17460875.1.4.389

21 January 2018

The effects of androgens and estrogens on preadipocyte proliferation in human adipose tissue: influence of gender and site

1 reference

https://api.crossref.org/works/10.2217%2F17460875.1.4.389

21 January 2018

Galectin-12 is required for adipogenic signaling and adipocyte differentiation

1 reference

https://api.crossref.org/works/10.2217%2F17460875.1.4.389

21 January 2018

Are there persons who are obese, but metabolically healthy?

1 reference

https://api.crossref.org/works/10.2217%2F17460875.1.4.389

21 January 2018

Relation of C-reactive protein to body fat distribution and features of the metabolic syndrome in Europeans and South Asians

1 reference

https://api.crossref.org/works/10.2217%2F17460875.1.4.389

21 January 2018

Identifiers

10.2217/17460875.1.4.389

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q56567724&oldid=1812034839"